How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
about
Protein quality control during erythropoiesis and hemoglobin synthesisMisfolded proteins: from little villains to little helpers in the fight against cancer.Epithelial cells augment barrier function via activation of the Toll-like receptor 2/phosphatidylinositol 3-kinase pathway upon recognition of Salmonella enterica serovar Typhimurium curli fibrils in the gut.CD14 protein acts as an adaptor molecule for the immune recognition of Salmonella curli fibers.Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system.Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System
P2860
How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
How a cell deals with abnormal ...... protein aggregation diseases.
@en
type
label
How a cell deals with abnormal ...... protein aggregation diseases.
@en
prefLabel
How a cell deals with abnormal ...... protein aggregation diseases.
@en
P2093
P2860
P356
P1433
P1476
How a cell deals with abnormal ...... protein aggregation diseases.
@en
P2093
Aigelsreiter A
Fuchsbichler A
Stumptner C
Zatloukal K
P2860
P304
P356
10.1159/000103374
P577
2007-01-01T00:00:00Z